News

Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), an early-stage biotechnology company that is focusing…

2 years ago

SmileDirectClub Introduces New Retainer Manufacturing Technology

Next Generation Process Leverages Patented Laser Technology To Enhance Comfort Robust Automations Improve Manufacturing Productivity And Efficiency NASHVILLE, Tenn., Sept.…

2 years ago

Organovo Announces Postponement of Annual Meeting of Stockholders

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), an early-stage biotechnology company that is focusing…

2 years ago

Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration

Alignment with the FDA on a regulatory path forward for the continued development of tebipenem Hbr FDA feedback indicates positive…

2 years ago

CymaBay Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

NEWARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing…

2 years ago

Satsuma Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

South San Francisco, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing…

2 years ago

SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference

BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company…

2 years ago

Alignment Healthcare Announces Completion of Debt Refinancing

ORANGE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (Alignment Healthcare or the Company) (NASDAQ: ALHC), a tech-enabled…

2 years ago

Protara Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the…

2 years ago

Selecta Biosciences to Participate at the H.C. Wainwright 24th Annual Global Investment Conference

WATERTOWN, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated…

2 years ago